Singular Health Group (ASX:SHG) Treasury Stock : A$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Singular Health Group Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Singular Health Group's treasury stock for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Singular Health Group Treasury Stock Historical Data

The historical data trend for Singular Health Group's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singular Health Group Treasury Stock Chart

Singular Health Group Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Treasury Stock

Singular Health Group Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Treasury Stock	Get a 7-Day Free Trial			-	-	-	-	-

Singular Health Group Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Singular Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singular Health Group Ltd (ASX:SHG) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

2/41 Discovery Drive Bibra, Bibra Lake, WA, AUS, 6163

Website

https://www.singular.health

Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.